Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • human_urostor
    Junior Member
    • Mar 2016
    • 1

    #1

    Cuffdiff confidence intervals - relative quantitation

    Hi all,

    I have not found any answers to this kind of question anywhere so I have to ask.
    I've done RNA-seq and analyzed it in tophat/cuffdiff (then cummeRbund but this is irrelevant here). I also did RT-qPCR on some genes to cross-validate my findings. My reference gene for RT-qPCR was one that was moderately, evenly expressed in all my samples (judging from FPKM). The expression level of all of my other genes was therefore noted as a fraction of the expression level of my reference gene in the same sample (RQ).

    To make a figure comparing the results from those two methods, I want to present the expression levels for genes of interest from RNA-seq as fractions of expression level of my reference gene too.

    My problem is: how to calculate the uncertainty in the relative FPKM value? From the research I have done, if FDR is left at 0.05, cuffdiff reports 95% confidence intervals calculated as in this paper: http://bioinformatics.oxfordjournals.../1026.abstract

    I have found two methods of calculating uncertainty when dividing two values.
    Method one: http://www.math-mate.com/chapter34_4.shtml (subsection "Division with two numbers with large errors – long method")
    Method two (let R be the relative expression): https://en.wikipedia.org/wiki/Propag...ce_measurement

    The problem with the first one is that (using my mathematical common sense) I would get a 95%*95%=90% CI, the resulting uncertainties seem too huge, and it seems not to be supported by any literature. The problem with the second method is that I need to use standard deviation, and the 95% CI is not exactly the SD.

    I would appreciate any help.

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
31 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
41 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Working...